Zahrat Al Waha For Trading Company's (TADAWUL:3007) Prospects Need A Boost To Lift Shares

When close to half the companies operating in the Packaging industry in Saudi Arabia have price-to-sales ratios (or "P/S") above 2.2x, you may consider Zahrat Al Waha For Trading Company (TADAWUL:3007) as an attractive investment with its 1.1x P/S ratio. Nonetheless, we'd need to dig a little deeper to determine if there is a rational basis for the reduced P/S.

View our latest analysis for Zahrat Al Waha For Trading

ps-multiple-vs-industry
SASE:3007 Price to Sales Ratio vs Industry May 8th 2025
Advertisement

How Zahrat Al Waha For Trading Has Been Performing

As an illustration, revenue has deteriorated at Zahrat Al Waha For Trading over the last year, which is not ideal at all. It might be that many expect the disappointing revenue performance to continue or accelerate, which has repressed the P/S. Those who are bullish on Zahrat Al Waha For Trading will be hoping that this isn't the case so that they can pick up the stock at a lower valuation.

Although there are no analyst estimates available for Zahrat Al Waha For Trading, take a look at this free data-rich visualisation to see how the company stacks up on earnings, revenue and cash flow.

Do Revenue Forecasts Match The Low P/S Ratio?

In order to justify its P/S ratio, Zahrat Al Waha For Trading would need to produce sluggish growth that's trailing the industry.

Retrospectively, the last year delivered a frustrating 3.5% decrease to the company's top line. This means it has also seen a slide in revenue over the longer-term as revenue is down 8.4% in total over the last three years. So unfortunately, we have to acknowledge that the company has not done a great job of growing revenue over that time.

In contrast to the company, the rest of the industry is expected to grow by 27% over the next year, which really puts the company's recent medium-term revenue decline into perspective.

With this information, we are not surprised that Zahrat Al Waha For Trading is trading at a P/S lower than the industry. However, we think shrinking revenues are unlikely to lead to a stable P/S over the longer term, which could set up shareholders for future disappointment. There's potential for the P/S to fall to even lower levels if the company doesn't improve its top-line growth.

What We Can Learn From Zahrat Al Waha For Trading's P/S?

Typically, we'd caution against reading too much into price-to-sales ratios when settling on investment decisions, though it can reveal plenty about what other market participants think about the company.

Our examination of Zahrat Al Waha For Trading confirms that the company's shrinking revenue over the past medium-term is a key factor in its low price-to-sales ratio, given the industry is projected to grow. At this stage investors feel the potential for an improvement in revenue isn't great enough to justify a higher P/S ratio. Given the current circumstances, it seems unlikely that the share price will experience any significant movement in either direction in the near future if recent medium-term revenue trends persist.

It is also worth noting that we have found 4 warning signs for Zahrat Al Waha For Trading (2 are significant!) that you need to take into consideration.

If companies with solid past earnings growth is up your alley, you may wish to see this free collection of other companies with strong earnings growth and low P/E ratios.

Valuation is complex, but we're here to simplify it.

Discover if Zahrat Al Waha For Trading might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About SASE:3007

Zahrat Al Waha For Trading

Engages in the manufacturing and sale of PET preforms and caps in the Kingdom of Saudi Arabia.

Moderate risk with adequate balance sheet.

Advertisement

Weekly Picks

TA
Talos
TSLA logo
Talos on Tesla ·

The "Physical AI" Monopoly – A New Industrial Revolution

Fair Value:US$665.3637.3% undervalued
45 users have followed this narrative
18 users have commented on this narrative
22 users have liked this narrative
MA
CSG logo
Marek_Trnka on CSG ·

Czechoslovak Group - is it really so hot?

Fair Value:€5547.4% undervalued
43 users have followed this narrative
1 users have commented on this narrative
13 users have liked this narrative
AL
alex30free
SECARE logo
alex30free on Swedencare ·

The Compound Effect: From Acquisition to Integration

Fair Value:SEK 46.2850.0% undervalued
12 users have followed this narrative
0 users have commented on this narrative
1 users have liked this narrative

Updated Narratives

AS
asaa
NAS logo
asaa on Norwegian Air Shuttle ·

Norwegian Air Shuttle's revenue will grow by 73.56% and profitability will soar

Fair Value:NOK 20091.2% undervalued
8 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
TI
TibiT
OLVAS logo
TibiT on Olvi Oyj ·

Investment Thesis: Olvi Oyj (OLVAS)

Fair Value:€46.3127.7% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
DA
DanielGC
UNH logo
DanielGC on UnitedHealth Group ·

UnitedHealth Group's Future Revenue Grows by 3.59%: What Will It Mean?

Fair Value:US$39525.8% undervalued
3 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

DA
davidlsander
UBI logo
davidlsander on Ubisoft Entertainment ·

Is Ubisoft the Market’s Biggest Pricing Error? Why Forensic Value Points to €33 Per Share

Fair Value:€33.887.4% undervalued
59 users have followed this narrative
5 users have commented on this narrative
25 users have liked this narrative
AN
AnalystConsensusTarget
MSFT logo
AnalystConsensusTarget on Microsoft ·

Analyst Commentary Highlights Microsoft AI Momentum and Upward Valuation Amid Growth and Competitive Risks

Fair Value:US$603.2233.5% undervalued
1277 users have followed this narrative
2 users have commented on this narrative
9 users have liked this narrative
AN
AnalystConsensusTarget
NVDA logo
AnalystConsensusTarget on NVIDIA ·

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026

Fair Value:US$253.0227.7% undervalued
1073 users have followed this narrative
6 users have commented on this narrative
32 users have liked this narrative
Advertisement